51 Days
Source:
الاقتصادية
_1777294237270_124456903.png&w=64&q=75){kind=small}
Source: الاقتصادية
51 Daysالاقتصادية
Source: الاقتصادية
51 DaysReady to play
Ready to play
Novartis Saudi Arabia plans to increase its investments in the Kingdom by 10% over the next five years, as part of an expansion plan to support the ambitious Saudi market in the pharmaceuticals and healthcare sector. Currently, the company's investments amount to approximately 300 million Riyals, with more than 140 registered products and around 200 employees, 70% of whom are national talents. The company also aims to boost local pharmaceutical manufacturing from four types of medicines to more before 2030, with the goal of reaching 10 million patients benefiting from its services by that year. This aligns with Saudi Arabia's Vision 2030 and the transformation of the healthcare sector.
Notice: This Is an AI-Generated Summary
Comments (0)